Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 1 |
2017 | 2 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
N Engl J Med. 2014 Jul 17;371(3):234-47. doi: 10.1056/NEJMoa1311274.
N Engl J Med. 2014.
PMID: 25014688
Free article.
Clinical Trial.
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial.
Paton NI, Kityo C, Thompson J, Nankya I, Bagenda L, Hoppe A, Hakim J, Kambugu A, van Oosterhout JJ, Kiconco M, Bertagnolio S, Easterbrook PJ, Mugyenyi P, Walker AS; Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team.
Paton NI, et al.
Lancet HIV. 2017 Aug;4(8):e341-e348. doi: 10.1016/S2352-3018(17)30065-6. Epub 2017 May 8.
Lancet HIV. 2017.
PMID: 28495562
Free PMC article.
Clinical Trial.
Item in Clipboard
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.
Hakim JG, Thompson J, Kityo C, Hoppe A, Kambugu A, van Oosterhout JJ, Lugemwa A, Siika A, Mwebaze R, Mweemba A, Abongomera G, Thomason MJ, Easterbrook P, Mugyenyi P, Walker AS, Paton NI; Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team.
Hakim JG, et al.
Lancet Infect Dis. 2018 Jan;18(1):47-57. doi: 10.1016/S1473-3099(17)30630-8. Epub 2017 Nov 3.
Lancet Infect Dis. 2018.
PMID: 29108797
Free PMC article.
Clinical Trial.
Item in Clipboard
Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index.
Shi Y, Thompson J, Walker AS, Paton NI, Cheung YB; EARNEST Trial Team.
Shi Y, et al.
Health Qual Life Outcomes. 2019 May 10;17(1):83. doi: 10.1186/s12955-019-1135-8.
Health Qual Life Outcomes. 2019.
PMID: 31077251
Free PMC article.
Clinical Trial.
Item in Clipboard
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.
Arenas-Pinto A, Thompson J, Musoro G, Musana H, Lugemwa A, Kambugu A, Mweemba A, Atwongyeire D, Thomason MJ, Walker AS, Paton NI; EARNEST Trial Team.
Arenas-Pinto A, et al.
J Neurovirol. 2016 Feb;22(1):104-13. doi: 10.1007/s13365-015-0374-7. Epub 2015 Aug 25.
J Neurovirol. 2016.
PMID: 26323809
Clinical Trial.
Item in Clipboard
Community capacity as means to improved health practices and an end in itself: evidence from a multi-stage study.
Underwood C, Boulay M, Snetro-Plewman G, Macwan'gi M, Vijayaraghavan J, Namfukwe M, Marsh D.
Underwood C, et al. Among authors: namfukwe m.
Int Q Community Health Educ. 2012-2013;33(2):105-27. doi: 10.2190/IQ.33.2.b.
Int Q Community Health Educ. 2012.
PMID: 23661414
Item in Clipboard
Cite
Cite